A Type 1 Diabetes Genetic Risk Score Predicts Progression of Islet Autoimmunity and Development of Type 1 Diabetes in Individuals at Risk
2018 · Diabetes Care · 165 citations
https://doi.org/10.2337/dc18-0087
J
John A. Wagner
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
328
Papers
18.9K
Citations
74
h-index
214
i10-index
John A. Wagner is an academic researcher from Cornell University. The author has contributed to research in topics: Diabetes Treatment and Management & Pharmacogenetics and Drug Metabolism & Lipoproteins and Cardiovascular Health. The author has an h-index of 74, co-authored 279 publications.
Papers by this author
worksMediation of NGF signaling by post-translational inhibition of HES-1, a basic helix–loop–helix repressor of neuronal differentiation
1997 · Genes & Development · 101 citations
https://doi.org/10.1101/gad.11.23.3168
Regulation of hippocampal neuronal differentiation by the basic helix-loop-helix transcription factors HES-1 and MASH-1
1999 · Journal of Neuroscience Research · 66 citations
https://doi.org/10.1002/(sici)1097-4547(19990501)56:3<229::aid-jnr2>3.0.co;2-z
Accelerating Drug Development Using Biomarkers: A Case Study with Sitagliptin, A Novel DPP4 Inhibitor for Type 2 Diabetes
2008 · The AAPS Journal · 50 citations
https://doi.org/10.1208/s12248-008-9041-8
Effects of CETP inhibition with anacetrapib on metabolism of VLDL-TG and plasma apolipoproteins C-II, C-III, and E
2017 · Journal of Lipid Research · 23 citations
https://doi.org/10.1194/jlr.m074880
Selecting Appropriate Clinical Trial Endpoints for Geroscience Trials: A Path Towards Consensus
2025 · Research Square · 0 citations
https://doi.org/10.21203/rs.3.rs-5920485/v1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat